Rahul Banerjee, MD, FACP

home / authors / rahul-banerjee-md-facp

Articles

QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C

January 31st 2025

This video segment discusses strategies to help CAR-T therapy patients maintain quality of life, focusing on lifestyle support, balancing work during and after treatment, and effective supportive care measures.

Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C

January 31st 2025

This video segment explores the challenges of managing neurologic toxicities, including ICANS, in CAR-T therapy, highlighting monitoring strategies, tools for early detection, and approaches to communicating risks with patients and caregivers.

Managing Adverse Events with CAR T-Cell Therapy: Best Practices for Myeloma Care Teams

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C

December 23rd 2024

Meet Sarah, a 55-year-old Businesswoman With Multiple Myeloma Considering CAR-T Therapy With Ide-cel

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C

December 23rd 2024